Study of an Investigational Medication for Patients with Previously Untreated Head and Neck Squamous Cell Carcinoma

Study identifier:D7919C00706

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Phase II Randomized, Double-blind, Placebo-controlled, Multicenter Comparative Study of ZD1839 250 mg or 500 mg (Iressa™) given either Continuously or Concomitantly with Cisplatin plus Radiotherapy for the Treatment of Patients with Previously Untreated Unresected Late Stage III/IV Non-Metastatic Head and Neck Squamous Cell Carcinoma

Medical condition

Carcinoma, Squamous Cell

Phase

Phase 2

Healthy volunteers

Yes

Study drug

ZD1839

Sex

All

Actual Enrollment

Study type

Interventional

Age

18 Years +

Date

Study Start Date: 01 Nov 2004

Primary Completion Date: 01 Jun 2008

Study Completion Date: 01 Jun 2008

Study design

Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: None
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Collaborators

Inclusion and exclusion criteria

Location

Research Site

Aurora, CO, United States

Location

Research Site

Dallas, TX, United States

Location

Research Site

Newark, DE, United States

Arms	Assigned Interventions

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=605&filename=CSR-D7919C00706.pdf
Download
CSR-D7919C00706.pdf
Download
Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca Clinical Study Information

800-236-9933

Study of an Investigational Medication for Patients with Previously Untreated Head and Neck Squamous Cell Carcinoma

Official Title

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Age

Date

Study design

Verification:

Sponsors

Collaborators

Inclusion Criteria

Exclusion Criteria

Research Site

Research Site

Research Site

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=605&filename=CSR-D7919C00706.pdf

CSR-D7919C00706.pdf

Trial Results Summaries

Contacts

Contact